Loading...
Novan, Inc.
NOVN•NASDAQ
Healthcare
Biotechnology
$0.09
$-0.03(-24.84%)

Novan, Inc. (NOVN) Balance Sheet Analysis
Novan, Inc. (NOVN) manages its money wisely, with plenty of N/A and N/A to cover its bills. The company’s long-term debts are manageable, balanced by steady -82.85%. Shareholders’ stake in the business has shrunk. Overall, the numbers show a cautious position, giving it room to invest, expand, or adapt. For investors, this paints a risky picture for the future.Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan